This webinar will focus on the critical chemistry, manufacturing and controls (CMC) elements of a product’s life cycle and how Lonza applies its knowledge and experience to provide the regulatory submissions support and strategy necessary for a successful biologics licence application (BLA). You can also learn how Lonza tailors and shortens a development timeline should a product be approved for one of the US Food and Drug Administration's expedited pathways to market.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center